544 related articles for article (PubMed ID: 15902796)
1. Conservative management of delayed, multicomponent coagulopathy following rattlesnake envenomation.
Camilleri C; Offerman S; Gosselin R; Albertson T
Clin Toxicol (Phila); 2005; 43(3):201-6. PubMed ID: 15902796
[TBL] [Abstract][Full Text] [Related]
2. Rattlesnake envenomation with neurotoxicity refractory to treatment with crotaline Fab antivenom.
Richardson WH; Goto CS; Gutglass DJ; Williams SR; Clark RF
Clin Toxicol (Phila); 2007; 45(5):472-5. PubMed ID: 17503249
[TBL] [Abstract][Full Text] [Related]
3. Recurrent hemorrhage after western diamondback rattlesnake envenomation treated with crotalidae polyvalent immune fab (ovine).
Fazelat J; Teperman SH; Touger M
Clin Toxicol (Phila); 2008 Nov; 46(9):823-6. PubMed ID: 18608290
[TBL] [Abstract][Full Text] [Related]
4. Late hematologic toxicity following treatment of rattlesnake envenomation with crotalidae polyvalent immune Fab antivenom.
Ruha AM; Curry SC; Albrecht C; Riley B; Pizon A
Toxicon; 2011 Jan; 57(1):53-9. PubMed ID: 20920516
[TBL] [Abstract][Full Text] [Related]
5. Continuous IV Crotalidae Polyvalent Immune Fab (Ovine) (FabAV) for selected North American rattlesnake bite patients.
Bush SP; Seifert SA; Oakes J; Smith SD; Phan TH; Pearl SR; Reibling ET
Toxicon; 2013 Jul; 69():29-37. PubMed ID: 23474267
[TBL] [Abstract][Full Text] [Related]
6. Recurrent coagulopathy with delayed significant bleeding after crotaline envenomation.
O'Brien NF; DeMott MC; Suchard JR; Clark RF; Peterson BM
Pediatr Emerg Care; 2009 Jul; 25(7):457-9. PubMed ID: 19606002
[TBL] [Abstract][Full Text] [Related]
7. Report of two cases: Rattlesnake venom-induced thrombocytopenia.
Odeleye AA; Presley AE; Passwater ME; Mintz PD
Ann Clin Lab Sci; 2004; 34(4):467-70. PubMed ID: 15648790
[TBL] [Abstract][Full Text] [Related]
8. Recurrent, persistent, or late, new-onset hematologic abnormalities in Crotaline snakebite.
Seifert SA; I Kirschner R; Martin N
Clin Toxicol (Phila); 2011 Apr; 49(4):324-9. PubMed ID: 21563909
[TBL] [Abstract][Full Text] [Related]
9. Delayed hematologic toxicity following rattlesnake envenomation unresponsive to crotalidae polyvalent antivenom.
Bailey AM; Justice S; Davis GA; Weant K
Am J Emerg Med; 2017 Jul; 35(7):1038.e1-1038.e2. PubMed ID: 28259369
[TBL] [Abstract][Full Text] [Related]
10. Coagulation parameters in copperhead compared to other Crotalinae envenomation: secondary analysis of the F(ab')
Gerardo CJ; Vissoci JR; Brown MW; Bush SP
Clin Toxicol (Phila); 2017 Feb; 55(2):109-114. PubMed ID: 27806644
[TBL] [Abstract][Full Text] [Related]
11. Tracheal intubation prevented with administration of Fab antivenom after severe crotaline envenomation.
Bebarta VS; Ferre RM; Peck M
J Emerg Med; 2010 Jul; 39(1):e81-3. PubMed ID: 18722730
[TBL] [Abstract][Full Text] [Related]
12. Crotalidae polyvalent immune Fab: in patients with North American crotaline envenomation.
Keating GM
BioDrugs; 2011 Apr; 25(2):69-76. PubMed ID: 21443271
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous Crotaline Fab antivenom for the treatment of rattlesnake envenomation in a porcine model.
Offerman SR; Barry JD; Richardson WH; Tong T; Tanen D; Bush SP; Clark RF
Clin Toxicol (Phila); 2009 Jan; 47(1):61-8. PubMed ID: 19153852
[TBL] [Abstract][Full Text] [Related]
14. Recurrent coagulopathy and thrombocytopenia in children treated with crotalidae polyvalent immune fab: a case series.
Miller AD; Young MC; DeMott MC; Ly BT; Clark RF
Pediatr Emerg Care; 2010 Aug; 26(8):576-82. PubMed ID: 20693856
[TBL] [Abstract][Full Text] [Related]
15. Pygmy rattlesnake envenomation treated with Crotalidae Polyvalent Immune Fab Antivenom.
King AM; Crim WS; Menke NB; Pizon AF
Toxicon; 2012 Dec; 60(7):1287-9. PubMed ID: 22963729
[TBL] [Abstract][Full Text] [Related]
16. Images in clinical medicine. Rattlesnake envenomation.
Levine M; Ruha AM
N Engl J Med; 2010 Jun; 362(23):2212. PubMed ID: 20558372
[No Abstract] [Full Text] [Related]
17. Coagulopathy as the main systemic manifestation after envenoming by a juvenile South American rattlesnake (Crotalus durissus terrificus): case report.
Bucaretchi F; De Capitani EM; Branco MM; Fernandes LC; Hyslop S
Clin Toxicol (Phila); 2013 Jul; 51(6):505-8. PubMed ID: 23713821
[TBL] [Abstract][Full Text] [Related]
18. Late, new-onset thrombocytopenia in a rattlesnake envenomation treated with a Fab antivenom.
Seifert SA; Cano DN
Clin Toxicol (Phila); 2013 Nov; 51(9):911-2. PubMed ID: 24066732
[No Abstract] [Full Text] [Related]
19. Crotaline Fab antivenom for the treatment of children with rattlesnake envenomation.
Offerman SR; Bush SP; Moynihan JA; Clark RF
Pediatrics; 2002 Nov; 110(5):968-71. PubMed ID: 12415038
[TBL] [Abstract][Full Text] [Related]
20. Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 2. Guidelines for clinical management with crotaline Fab antivenom.
Boyer LV; Seifert SA; Cain JS
Ann Emerg Med; 2001 Feb; 37(2):196-201. PubMed ID: 11174239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]